Prenatal THC and the Placenta: Why Normal Maternal Weight Did Not Exclude Fetal Effects in Rats
Normal maternal weight gain did not exclude fetal-growth and placental findings in a rat THC experiment. Different maternal and fetal endpoints can respond differently to the same exposure.
The exposure and assessments
The investigators administered THC or vehicle to pregnant Wistar rats during gestation. They assessed maternal food intake and weight, pregnancy outcomes, offspring growth, and placental structure. Additional experiments used human BeWo trophoblast cells.
The rat exposure was by injection. The cell experiments were in vitro, not measurements from human pregnancies. Neither should be relabeled as a clinical trial of cannabis use during pregnancy.
Positive findings alongside unchanged outcomes
Maternal food intake, weight gain, gestational length, and several reproductive outcomes did not significantly change. Offspring nevertheless showed growth restriction at birth, followed by catch-up growth by postnatal day 21.
Placental changes were concentrated in the labyrinth, including altered blood-space and vascular features and reduced expression of selected transport-related markers. The junctional zone did not show the same pattern. This anatomical specificity matters when describing a mechanism.
What the study does not prove
Catch-up growth is not proof that every biological consequence resolved, but it also is not proof that these offspring developed a particular adult disease. Proposed long-term implications require appropriate follow-up evidence.
The design helps investigate THC separately from smoke and other cannabis constituents. Species, route, dose, and developmental differences limit direct human application. A clinical opinion about fetal growth must evaluate alternative explanations and the actual exposure history; neither maternal weight nor a cannabinoid result alone establishes causation.
Related reading: the limits of interpreting THC blood concentrations.
Primary research
Bryony V. Natale; Katarina N. Gustin; Kendrick Lee; Alison C. Holloway; Steven R. Laviolette; David R. C. Natale; Daniel B. Hardy. Δ9-tetrahydrocannabinol exposure during rat pregnancy leads to symmetrical fetal growth restriction and labyrinth-specific vascular defects in the placenta. Scientific Reports (2020). DOI: 10.1038/s41598-019-57318-6.
